{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:51:04Z","timestamp":1793083864199,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Crizotinib is a targeted therapy for metastatic non-small cell lung cancer (NSCLC) that is ALK- or ROS1-positive, as well as for conditions such as ALK-positive anaplastic large cell lymphoma and inflammatory myofibroblastic tumor. However, the associated toxicity poses a significant challenge to its use. To mitigate this issue, a novel dry powder inhalation formulation was developed using Crizotinib-loaded polyethylene glycol-based polymeric nanoparticles (NPs). These nanoparticles were created through a nanoprecipitation approach and improved employing central composite design. The capabilities of the formulation were assessed with Anderson Cascade Impactor, revealing a fine particle fraction of 56.2% and a mass median aerodynamic diameter of around 1.5\u00a0\u03bcm, indicating appropriate aerodynamic characteristics for inhalation. Key properties of the optimized nanoparticles included Encapsulation efficiency (82.3%, Zeta potential (-31.9 mV), Particle size (167\u00a0nm), Polydispersity index (0.462) and Release efficiency (60.6%) In vitro studies indicated that the polymeric nanoparticles exhibited greater anticancer activity compared to free Crizotinib. Additional characterization using techniques like XRD, DSC, FTIR, and SEM confirmed that the polymeric nanoparticle formulation has promising physicochemical properties, suggesting it could enhance local drug delivery and efficacy in lung cancer treatment while potentially reducing systemic toxicity.<\/jats:p>","DOI":"10.1186\/s12885-025-15015-w","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:29:35Z","timestamp":1759840175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Innovative inhalable dry powder: nanoparticles loaded with Crizotinib for targeted lung cancer therapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Faiza","family":"Naureen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maqsood Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazli Nasir","family":"Fazli Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Saboor","family":"Pirzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamelah Saleh","family":"Al-Otaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Daglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"1","key":"15015_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/pharmaceutics10010033","volume":"10","author":"P Parashar","year":"2018","unstructured":"Parashar P, Rathor M, Dwivedi M, Saraf SA. Hyaluronic acid decorated naringenin nanoparticles: appraisal of chemopreventive and curative potential for lung cancer. Pharmaceutics. 2018;10(1):33.","journal-title":"Pharmaceutics"},{"key":"15015_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejps.2015.10.021","volume":"81","author":"B Mandal","year":"2016","unstructured":"Mandal B, Mittal NK, Balabathula P, Thoma LA, Wood GC. Development and in vitro evaluation of core\u2013shell type lipid\u2013polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer. Eur J Pharm Sci. 2016;81:162\u201371.","journal-title":"Eur J Pharm Sci"},{"issue":"29","key":"15015_CR3","doi-asserted-by":"publisher","first-page":"1700623","DOI":"10.1002\/smll.201700623","volume":"13","author":"W Cheng","year":"2017","unstructured":"Cheng W, Liang C, Xu L, Liu G, Gao N, Tao W, et al. TPGS-functionalized polydopamine\u2010modified mesoporous silica as drug nanocarriers for enhanced lung cancer chemotherapy against multidrug resistance. Small. 2017;13(29):1700623.","journal-title":"Small"},{"key":"15015_CR4","doi-asserted-by":"crossref","unstructured":"Kola Srinivas NS, Verma R, Pai Kulyadi G, Kumar L. A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization. Int J Nanomed. 2017;12:15\u201328.","DOI":"10.2147\/IJN.S122729"},{"issue":"1","key":"15015_CR5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1080\/10717544.2017.1384862","volume":"24","author":"XL Ni","year":"2017","unstructured":"Ni XL, Chen LX, Zhang H, Yang B, Xu S, Wu M, et al. In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer. Drug Delivery. 2017;24(1):1501\u201312.","journal-title":"Drug Delivery"},{"key":"15015_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2016.03.025","volume":"103","author":"R Said-Elbahr","year":"2016","unstructured":"Said-Elbahr R, Nasr M, Alhnan MA, Taha I, Sammour O. Nebulizable colloidal nanoparticles co-encapsulating a COX-2 inhibitor and a herbal compound for treatment of lung cancer. Eur J Pharm Biopharm. 2016;103:1\u201312.","journal-title":"Eur J Pharm Biopharm"},{"key":"15015_CR7","doi-asserted-by":"crossref","unstructured":"Rosiere R, Amighi K, Wauthoz N. Nanomedicine-based inhalation treatments for lung cancer. In P. Kesharwani (Ed.) Nanotechnology-based Target Drug Delivery Syst Lung Cancer. 2019. p.249\u201368.","DOI":"10.1016\/B978-0-12-815720-6.00010-1"},{"issue":"1\u20132","key":"15015_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijpharm.2010.05.032","volume":"395","author":"IM El-Sherbiny","year":"2010","unstructured":"El-Sherbiny IM, Smyth HD. Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery:(I) self-assembled nanoparticles encapsulated in respirable\/swellable semi-IPN microspheres. Int J Pharm. 2010;395(1\u20132):132\u201341.","journal-title":"Int J Pharm"},{"key":"15015_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jconrel.2018.12.013","volume":"295","author":"C Xu","year":"2019","unstructured":"Xu C, Wang Y, Guo Z, Chen J, Lin L, Wu J, et al. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy. J Controlled Release. 2019;295:153\u201363.","journal-title":"J Controlled Release"},{"issue":"4","key":"15015_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/1735-5362.235156","volume":"13","author":"P Ghasemiyeh","year":"2018","unstructured":"Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 2018;13(4):288\u2013303.","journal-title":"Res Pharm Sci"},{"key":"15015_CR11","doi-asserted-by":"crossref","unstructured":"Meenach SA, Vogt FG, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine Poly (ethylene glycol)(DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols. Int J Nanomed. 2013; (8):275\u201393.","DOI":"10.2147\/IJN.S30724"},{"issue":"1","key":"15015_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3109\/1061186X.2015.1055572","volume":"24","author":"S Pawar","year":"2016","unstructured":"Pawar S, Vavia P. Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin. J Drug Target. 2016;24(1):68\u201379.","journal-title":"J Drug Target"},{"key":"15015_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.etap.2015.12.004","volume":"41","author":"E A\u015f\u0131k","year":"2016","unstructured":"A\u015f\u0131k E, Aslan TN, Volkan M, G\u00fcray NT. 2-Amino-2-deoxy-glucose conjugated Cobalt ferrite magnetic nanoparticle (2DG-MNP) as a targeting agent for breast cancer cells. Environ Toxicol Pharmacol. 2016;41:272\u20138.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"1","key":"15015_CR14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/10717544.2019.1576801","volume":"26","author":"X Wan","year":"2019","unstructured":"Wan X, Liu C, Lin Y, Fu J, Lu G, Lu Z. pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer. Drug Delivery. 2019;26(1):470\u201380.","journal-title":"Drug Delivery"},{"issue":"1","key":"15015_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1208\/s12249-015-0473-z","volume":"18","author":"X Fang","year":"2017","unstructured":"Fang X, Xu Y, Wang S, Wan J, He C, Chen M. Pluronic F68-linoleic acid nano-spheres mediated delivery of gambogic acid for cancer therapy. AAPS PharmSciTech. 2017;18(1):147\u201355.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"15015_CR16","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.3390\/molecules18066425","volume":"18","author":"H Zhu","year":"2013","unstructured":"Zhu H, Zhao J, Lin X, Hong Y, Li C, Yang Z. Design, synthesis and evaluation of dual-modality glyco-nanoparticles for tumor imaging. Molecules. 2013;18(6):6425\u201338.","journal-title":"Molecules"},{"key":"15015_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1208\/s12249-017-0859-1","volume":"19","author":"Q Zhong","year":"2018","unstructured":"Zhong Q. Co-spray dried mannitol\/poly (amidoamine)-doxorubicin dry-powder inhaler formulations for lung adenocarcinoma: morphology, in vitro evaluation, and aerodynamic performance. AAPS PharmSciTech. 2018;19:531\u201340.","journal-title":"AAPS PharmSciTech"},{"key":"15015_CR18","doi-asserted-by":"publisher","first-page":"101570","DOI":"10.1016\/j.jddst.2020.101570","volume":"56","author":"M Otroj","year":"2020","unstructured":"Otroj M, Taymouri S, Varshosaz J, Mirian M. Preparation and characterization of dry powder containing Sunitinib loaded PHBV nanoparticles for enhanced pulmonary delivery. J Drug Deliv Sci Technol. 2020;56:101570.","journal-title":"J Drug Deliv Sci Technol"},{"key":"15015_CR19","doi-asserted-by":"crossref","unstructured":"Tan M-e, He C-h, Jiang W, Zeng C, Yu N, Huang W et al. Development of solid lipid nanoparticles containing total flavonoid extract from dracocephalum Moldavica L. and their therapeutic effect against myocardial ischemia\u2013reperfusion injury in rats. Int J Nanomed. 2017; (12):3253\u201365.","DOI":"10.2147\/IJN.S131893"},{"key":"15015_CR20","doi-asserted-by":"crossref","unstructured":"Burke K. Perspective on density functional theory. J Chem Phys. 2012;136(15):150901-9.","DOI":"10.1063\/1.4704546"},{"issue":"20","key":"15015_CR21","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1093\/bioinformatics\/btu426","volume":"30","author":"E Krieger","year":"2014","unstructured":"Krieger E, Vriend G. YASARA View\u2014molecular graphics for all devices\u2014from smartphones to workstations. Bioinformatics. 2014;30(20):2981\u20132.","journal-title":"Bioinformatics"},{"issue":"12","key":"15015_CR22","doi-asserted-by":"publisher","first-page":"i169","DOI":"10.1093\/bioinformatics\/btp200","volume":"25","author":"A Rizk","year":"2009","unstructured":"Rizk A, Batt G, Fages F, Soliman S. A general computational method for robustness analysis with applications to synthetic gene networks. Bioinformatics. 2009;25(12):i169\u201378.","journal-title":"Bioinformatics"},{"issue":"3","key":"15015_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.drudis.2018.11.018","volume":"24","author":"CH Mehta","year":"2019","unstructured":"Mehta CH, Narayan R, Nayak UY. Computational modeling for formulation design. Drug Discovery Today. 2019;24(3):781\u20138.","journal-title":"Drug Discovery Today"},{"key":"15015_CR24","doi-asserted-by":"crossref","unstructured":"Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Chemical biology: methods and protocols. 2015; (1263):243\u201350.","DOI":"10.1007\/978-1-4939-2269-7_19"},{"issue":"2","key":"15015_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"10","key":"15015_CR26","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/pharmaceutics13101632","volume":"13","author":"MA Khan","year":"2021","unstructured":"Khan MA, Khan S, Kazi M, Alshehri SM, Shahid M, Khan SU, et al. Norfloxacin loaded lipid polymer hybrid nanoparticles for oral administration: fabrication, characterization, in Silico modelling and toxicity evaluation. Pharmaceutics. 2021;13(10):1632.","journal-title":"Pharmaceutics"},{"key":"15015_CR27","unstructured":"Pal SL, Jana U, Manna PK, Mohanta GP, Manavalan R, Nanoparticle. An overview of Preparation and characterization. J Appl Pharm Sci. 2011;1(6):228\u201334."},{"issue":"1","key":"15015_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jconrel.2004.01.017","volume":"96","author":"J Jaiswal","year":"2004","unstructured":"Jaiswal J, Gupta SK, Kreuter J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J Controlled Release. 2004;96(1):169\u201378.","journal-title":"J Controlled Release"},{"issue":"10","key":"15015_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.farmac.2005.06.016","volume":"60","author":"A Bozkir","year":"2005","unstructured":"Bozkir A, Saka OM. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. Il Farmaco. 2005;60(10):840\u20136.","journal-title":"Il Farmaco"},{"issue":"22","key":"15015_CR30","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.3390\/molecules26226763","volume":"26","author":"M Umair","year":"2021","unstructured":"Umair M, Jabbar S, Nasiru MM, Lu Z, Zhang J, Abid M, et al. Ultrasound-assisted extraction of carotenoids from Carrot pomace and their optimization through response surface methodology. Molecules. 2021;26(22):6763.","journal-title":"Molecules"},{"issue":"2","key":"15015_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.5530\/ijper.55.2.77","volume":"55","author":"H Chinthaginjala","year":"2021","unstructured":"Chinthaginjala H, Ahad HA, Bhargav E, Pradeepkumar B. Central composite design aided formulation development and optimization of Clarythromycin extended-release tablets. Indian J Pharm Educ Res. 2021;55(2):395\u2013406.","journal-title":"Indian J Pharm Educ Res"},{"issue":"18","key":"15015_CR32","doi-asserted-by":"publisher","first-page":"5432","DOI":"10.3390\/molecules26185432","volume":"26","author":"H Hassan","year":"2021","unstructured":"Hassan H, Adam SK, Alias E, Meor Mohd Affandi MMR, Shamsuddin AF, Basir R. Central composite design for formulation and optimization of solid lipid nanoparticles to enhance oral bioavailability of acyclovir. Molecules. 2021;26(18):5432.","journal-title":"Molecules"},{"key":"15015_CR33","volume-title":"Dekker encyclopedia of nanoscience and nanotechnology","author":"JA Schwarz","year":"2004","unstructured":"Schwarz JA, Contescu CI, Putyera K. Dekker encyclopedia of nanoscience and nanotechnology. CRC; 2004."},{"issue":"5","key":"15015_CR34","first-page":"1227","volume":"3","author":"S preet Kaur","year":"2011","unstructured":"preet Kaur S, Rao R, Hussain A, Khatkar S. Preparation and characterization of Rivastigmine loaded Chitosan nanoparticles. J Pharm Sci Res. 2011;3(5):1227.","journal-title":"J Pharm Sci Res"},{"issue":"8","key":"15015_CR35","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/03639045.2020.1788063","volume":"46","author":"N Satari","year":"2020","unstructured":"Satari N, Taymouri S, Varshosaz J, Rostami M, Mirian M. Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy. Drug Dev Ind Pharm. 2020;46(8):1265\u201377.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"15015_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0939-6411(03)00020-1","volume":"55","author":"A Dubes","year":"2003","unstructured":"Dubes A, Parrot-Lopez H, Abdelwahed W, Degobert G, Fessi H, Shahgaldian P, et al. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur J Pharm Biopharm. 2003;55(3):279\u201382.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"15015_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3109\/21691401.2014.944645","volume":"44","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang J. Preparation of Budesonide nanosuspensions for pulmonary delivery: characterization, in vitro release and in vivo lung distribution studies. Artif Cells Nanomed Biotechnol. 2016;44(1):285\u20139.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"15015_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-20-93","volume":"20","author":"AS Shete","year":"2012","unstructured":"Shete AS, Yadav AV, Murthy SM. Chitosan and Chitosan chlorhydrate based various approaches for enhancement of dissolution rate of carvedilol. DARU J Pharm Sci. 2012;20:1\u20139.","journal-title":"DARU J Pharm Sci"},{"issue":"2","key":"15015_CR39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","volume":"70","author":"J-Y Fang","year":"2008","unstructured":"Fang J-Y, Fang C-L, Liu C-H, Su Y-H. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008;70(2):633\u201340.","journal-title":"Eur J Pharm Biopharm"},{"key":"15015_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40199-015-0128-3","volume":"23","author":"HA Ebrahimi","year":"2015","unstructured":"Ebrahimi HA, Javadzadeh Y, Hamidi M, Jalali MB. Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants\/stabilizers on physicochemical properties of nanoparticles. DARU J Pharm Sci. 2015;23:1\u201311.","journal-title":"DARU J Pharm Sci"},{"key":"15015_CR41","unstructured":"Gerwert K, K\u00f6tting C. Fourier transform infrared (FTIR) spectroscopy. Encyclopedia of Life Sciences (ELS). 2010."},{"issue":"6","key":"15015_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.addr.2007.04.004","volume":"59","author":"A Radomska-Soukharev","year":"2007","unstructured":"Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev. 2007;59(6):411\u20138.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"15015_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijpharm.2010.01.009","volume":"388","author":"U Bhardwaj","year":"2010","unstructured":"Bhardwaj U, Burgess DJ. A novel USP apparatus 4 based release testing method for dispersed systems. Int J Pharm. 2010;388(1\u20132):287\u201394.","journal-title":"Int J Pharm"},{"key":"15015_CR44","doi-asserted-by":"crossref","unstructured":"Daabees H. Selective differential spectrophotometric methods for determination of niclosamide and drotaverine hydrochloride. 2000.","DOI":"10.1080\/00032710008543080"},{"issue":"2","key":"15015_CR45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","volume":"45","author":"A zur M\u00fchlen","year":"1998","unstructured":"zur M\u00fchlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013drug release and release mechanism. Eur J Pharm Biopharm. 1998;45(2):149\u201355.","journal-title":"Eur J Pharm Biopharm"},{"key":"15015_CR46","unstructured":"Chapter G, 1225. Validation of compendial methods, United States Pharmacopeia 30, National Formulary 25, Rockville, Md., USA, The United States Pharmacopeial Convention. Inc, USP 5p. 2007."},{"issue":"1\u20132","key":"15015_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijpharm.2003.11.023","volume":"271","author":"M Leane","year":"2004","unstructured":"Leane M, Nankervis R, Smith A, Illum L. Use of the ninhydrin assay to measure the release of Chitosan from oral solid dosage forms. Int J Pharm. 2004;271(1\u20132):241\u20139.","journal-title":"Int J Pharm"},{"key":"15015_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1208\/pt040454","volume":"4","author":"JP Mitchell","year":"2003","unstructured":"Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS PharmSciTech. 2003;4:425\u201333.","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"15015_CR49","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3390\/pharmaceutics15102373","volume":"15","author":"MA Khattak","year":"2023","unstructured":"Khattak MA, Iqbal Z, Nasir F, Neau SH, Khan SI, Hidayatullah T, et al. Tamoxifen-Loaded Eudragit nanoparticles: quality by design approach for optimization of nanoparticles as delivery system. Pharmaceutics. 2023;15(10):2373.","journal-title":"Pharmaceutics"},{"issue":"13","key":"15015_CR50","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.3390\/molecules27134005","volume":"27","author":"F Naureen","year":"2022","unstructured":"Naureen F, Shah Y, Shah SI, Abbas M, Rehman IU, Muhammad S, et al. Formulation development of Mirtazapine liquisolid compacts: optimization using central composite design. Molecules. 2022;27(13):4005.","journal-title":"Molecules"},{"key":"15015_CR51","doi-asserted-by":"crossref","unstructured":"Conte G, d\u2019Angelo I, M\u00fcller J, Winkeljann B, Carneiro S, Merkel OM, Ungaro F. Pulmonary delivery of nucleic acids. In: Respiratory delivery of biologics, nucleic acids and vaccines.\u00a0Cham: Springer International Publishing; 2024. (8). p. 93\u2013122.\u00a0","DOI":"10.1007\/978-3-031-47567-2_5"},{"issue":"9","key":"15015_CR52","doi-asserted-by":"publisher","first-page":"13197","DOI":"10.1021\/acsami.4c16840","volume":"17","author":"VM de Oliveira Cardoso","year":"2024","unstructured":"de Oliveira Cardoso VM, Bistaffa MJ, Sterman RG, de Lima LL, Toldo GS, Cancino-Bernardi J, Zucolotto V. Nanomedicine innovations for lung cancer diagnosis and therapy. ACS Appl Mater Interfaces. 2024;17(9):13197.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"15015_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.52794\/hujpharm.1566707","volume":"45","author":"K Parmar","year":"2025","unstructured":"Parmar K, Mav U. Inhalable Pyrazinamide loaded lipid polymer hybrid nanoparticles: in vitro and in vivo lung deposition studies. Hacettepe Univ J Fac Pharm. 2025;45(1):57\u201370.","journal-title":"Hacettepe Univ J Fac Pharm"},{"key":"15015_CR54","doi-asserted-by":"crossref","unstructured":"Panovich PM, Ganesan A, Angadi AR, Piotrowski-Daspit AS. Recent advances in the application of polymeric nanoparticles to the pulmonary delivery of mRNA. Nanomedicine. 2025;1:1\u20137.","DOI":"10.1080\/17435889.2025.2509477"},{"issue":"9","key":"15015_CR55","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/17435889.2025.2485669","volume":"20","author":"BJ Heiser","year":"2025","unstructured":"Heiser BJ, Veyssi A, Ghosh D. Recent strategies for enhanced delivery of mRNA to the lungs. Nanomedicine. 2025;20(9):1043\u201369.","journal-title":"Nanomedicine"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15015-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15015-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15015-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:28:25Z","timestamp":1759843705000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15015-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15015"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15015-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1526"}}